Skip to content
Skip to footer
Home
Solution
Team
News
Contact
News
Close
Home
Solution
Team
News
Contact
April 24, 2023
Sartar received Orphan Drug Designation from the FDA
April 17, 2023
Meet us in LSX Congress 2023!
March 29, 2023
Sartar received Orphan Drug Designation in EU
January 5, 2023
Maria Lahtinen appointed as a Quality Director
June 15, 2022
Sartar is strengthening its board of directors
May 20, 2022
Sartar featured on RTL7
May 16, 2022
Sartar on stage at the Anglonordic 2022 Life Science Conference
November 21, 2021
NOME Annual Meeting in Copenhagen on November 23rd 2021
October 29, 2021
Sartar Therapeutics was selected to NOME mentoring program
September 20, 2021
Business Finland granted Sartar R&D Funding
August 20, 2021
Mikael Maksimow joins Sartar as a COO. Welcome!
July 20, 2021
Sartar’s therapy method featured in Drug Target Review
Posts navigation
Page
1
Page
2
>
